| Line Item | 2022-07-31 | Y/Y |
|---|---|---|
| Revenue | $1.58B | +13.4% |
| Cost of Revenue | $321.2M | +10.0% |
| Gross Profit | $1.26B | +14.3% |
| R&D Expense | $572.0M | +2.7% |
| SG&A Expense | $166.4M | +8.2% |
| Operating Income | -$457.4M | +30.8% |
| Pre-tax Income | -$778.3M | +23.4% |
| Income Tax | $19.3M | +4.2% |
| Net Income | -$797.5M |
| Line Item | 2022-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $402.9M | +41.0% |
| Accounts Receivable | $124.6M | -31.1% |
| Current Assets | $1.66B | +6.1% |
| Total Assets | $2.37B | +3.9% |
| Current Liabilities | $1.15B | +24.0% |
| Total Liabilities | $3.16B | -4.1% |
| Stockholders' Equity | -$790.2M | +21.9% |
| Line Item | 2022-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $67.5M | +167.7% |
| Capital Expenditures | $49.1M | -16.4% |
| Investing Cash Flow | -$54.2M | +90.9% |
| Financing Cash Flow | $103.6M | -84.4% |
| Free Cash Flow | $18.5M | +111.7% |
| +22.9% |
| EPS (Basic) | -$3.62 | +27.7% |
| EPS (Diluted) | -$3.62 | +27.7% |